breast cancer

NICE recommends pembrolizumab for 1,600 more people with breast cancer

Posted in Medicine on 22nd Nov, 2022
by Alex Muller

Clinical trials have shown that this combined approach can reduce the chance of Breast Cancer growing or progressing by 37% compared to chemotherapy alone.